The 15-lipoxygenase (/ox) gene is expressed in a tissue-specific manner, predominantly in erythroid cells but also in airway epithelial cells and eosinophils. We demonstrate in this report that the 5' flanking DNA of the 15-lox gene contains sequences which downregulate its activity in a variety of non-erythroid cell lines but not in two erythroid cell lines. The element has characteristics of a transcriptional 'silencer' since it functions in both orientations. The main activity of the silencer has been mapped to the first 900 bp of 5' flanking DNA, which contains nine binding sites for a nuclear factor present in non-erythroid cells but not in erythroid cells. These binding sites have similar sequences and multiple copies of the binding sites confer tissue-specific down-regulation when attached to a minimal fox promoter fragment. The 5' flanking DNA also contains a cluster of three binding sites for the GATA family of transcription factors.
INTRODUCTION
Studies of the regulation of genes that are highly expressed in erythroid cells, including the globin genes, both by our own group and others, have defined the importance of cw-control regions which function due to the binding of members of the GATA family of transcription factors (particularly GATA-1) in conjunction with other ubiquitous factors (1,2, reviewed in 3 and 4). Recently, we have also presented evidence for a role of members of the Ets family of transcription factors in the up-regulation of the glutathione peroxidase gene in erythroid cells (5) .
Evidence has also accumulated for the importance of negative control of transcription of genes in a wide variety of contexts (reviewed in [6] [7] [8] [9] [10] [11] . In the context of erythroid-specific gene expression in particular, there have been various reports of negative regulation of globin (12) (13) (14) (15) (16) (17) (18) (19) and non-globin genes such as the histone H5 gene (20, 21) , the erythropoietin receptor gene (22) and the glycophorin B gene (23) .
In this report, we have investigated the mechanisms of tissue-specific regulation of the 15-lox gene in erythroid cells.
The LOXs are a family of enzymes which catalyse the dioxygenation of polyenoic acids or their derivatives containing at least one l,4-cw,cw-pentadiene system (24) . Different cells, such as leukocytes, platelets and endothelial cells contain LOXs of different specificities according to the hydroperoxide products produced with arachidonic acid (5,8,11,14- all-cw-eicosatetraenoic acid) as substrate. Three different enzymes have been extensively characterised: the 5-, 12-and 15-LOXs, although other LOX activities (such as 8-specificity) have also been reported. The 15-LOX is expressed predominantly in reticulocytes, where it plays a role in mitochondrial degradation (25) , but also in eosinophils and epithelial cells of the bronchial airways (26) (27) (28) . Expression of the 15-lox gene is regulated both at the level of transcription (29) and mRNA translation during reticulocyte maturation (30) . In previous work, we isolated the rabbit 15-lox gene and defined its exon/intron structure and transcription start site in erythroid cells (31) .
In this report we demonstrate the importance of negative control mechanisms in the erythroid-specific expression of the 15-lox gene. We show that the 5'-flanking region of the 15-lox gene contains a tissue-specific transcriptional silencer which seems to function by binding of a novel factor present in non-expression tissues that is not the previously described negative regulator, YY1.
MATERIALS AND METHODS
The methods for cell culture, transient transfections and CAT assays, preparation of nuclear protein extracts, DNase I footprinting, electrophoretic mobility shift assays (EMSAs) and generation of site-directed mutations by the polymerase chain reaction (PCR) have all recently been described in detail (5) .
Cells and cell culture
Adherent mouse erythroleukemia (MEL) cells (F4-12B2; a gift from W. Ostertag, Hamburg, Germany), mouse epithelial cell line C5 (32) , STO mouse fibroblasts, HepG2 human liver cells, HeLa cells, the rabbit skin fibroblast line Rab 9, and the rabbit lung fibroblast cell line R9AB were obtained from the European Collection of Animal Cell Cultures, Porton Down, UK and were grown in a modification of Eagle's minimal essential medium with double concentrations of amino acids and vitamins, 10% fetal calf * To whom correspondence should be addressed serum (Tissue Culture Services) and in transient transfection experiments with 100 |ig streptomycin and 37.5 \ig penicillin/ml. The human erythroid/megakaryocyte K562 cell line was grown in RPMI 1640 medium supplemented with 10% fetal calf serum.
Plasmid constructions
Plasmids pCAT19, pCAT-40, pCAT-150 and pHSVfJGal were constructed as previously described (31) . pCAT-40 and pCAT-150 contain sequences extending from -40 and -150 to +20 bp (with respect to the transcription initiation site), respectively, linked to the bacterial chloramphenicol acetyltransferase gene (CAT) and transcriptional termination sequences of the herpes simplex virus type 2 (HSV-2) immediate-early 5 gene (TE-5). pCAT-2700 was obtained by co-ligation of a 1000 bp Sstl-Xbal fragment from pCAT-150 (containing 15-lox sequences from -150 to +20 bp, the CAT gene and the HSV-2 IE-5 transcriptional termination sequences) with a 2550 bp Kpnl-Sstl fragment of the 15-lox genomic clone (containing sequences from -2700 to -150 bp) into Kpnl-Xbal digested pUC19. pCAT-315 contains a 335 bp Smal-BamHl fragment from pCAT-2700 containing 15-lox sequences from -315 to +20 bp inserted into pC AT 19. pC AT-430 contains 15-lox sequences from -430 to +20 bp and was obtained by insertion of a 700 bp EcoKl fragment of pCAT-2700 into EcoRl cut pCAT19. pCAT-930 was obtained by insertion of a 615 bp Smal fragment from pCAT-2700 containing 15-lox sequences between -930 and -315 bp into Smal digested pCAT-315. pCAT-1800 and pCAT-2200 contain 15-lox sequences from -1800 and -2200 to +20 bp, respectively. These plasmids were constructed by the isolation of a Kpnl-Hindlll fragment of pCAT-2700 containing 15-lox 5' flanking sequences and the CAT gene. This fragment was partially digested by Taql or Pstl and fragments containing 1800 or 2200 bp of 15-lox sequence linked to the CAT gene were isolated and cloned into pUC19. The mini-gene construct was obtained by the cloning of a 4600 bp partial Xbal-Hindlll fragment from immediately downstream of the 15-lox gene into Xbal-Hindlll digested pCAT-2700. pC AT-150(0.78)5'-contains a 780 bp Sstl fragment from -930 to -150 bp in the reverse orientation and was prepared by cloning this fragment into Sstl digested pCAT-930. pCAT-150(0.78)3'+ and pCAT-150(0.78)3'-were prepared by cloning the bluntended 780 bp Sstl fragment in both orientations into blunt-ended, Hindlll digested pCAT-150. pCAT-150(2.55)5'-contains a 2550 bp Sstl fragment of 15-lox sequence from -2700 to -150 bp in the reverse orientation and was prepared by cloning this fragment into Sstl digested pCAT-2700. pCAT-150(2.55)3'+ and pCAT-150(2.55)3'-constructs were obtained by cloning the blunt-ended-2550 bpSstl fragment in both orientations into blunt-ended Hindlll digested pCAT-150. pCAT-150(Fp 4) 4 and pCAT-150(Fp 5)2 were prepared by cloning four copies of the Fp 4 binding site (oligonucleotide Fp 4) or two copies of the Fp 5 binding site (oligonucleotide Fp 5) linked head-to-tail in the natural orientation into the blunt-ended Sstl site of pCAT-150. Concatamers were prepared using oligonucleotide primers containing a BspMl restriction site as previously described (33) . pCAT-150(GS) and pCAT-150(GL) constructs contain 15-lox sequences from -551 to -736 bp and -551 to -930 bp, respectively, prepared by PCR (using primers L-2 and L-3 for GS and primers L-l and L-3 for GL) and cloned into Sstl digested pCAT-150. pCAT-150(GS) contains FP 8 and pCAT-150(GL) contains FPs 8-11 linked to the minimal 150 bp 15-lox promoter.
The pGPY289/2.55to construct contains the 2.55 kb Kpnl-Sstl fragment of the 15-lox gene from -2700 to -150 bp inserted into the Sstl site upstream of the 289 bp glutathione peroxidase (GPX) promoter/CAT construct pGPY289 (5) .
The integrity of all constructs was determined by restriction enzyme site mapping and all constructs produced by PCR were sequenced by the dideoxy chain termination method (34) .
Oligonucleotide PCR primers
The following oligonucleotides were used in this study (all sequences are written 5'-•3'): (35) . Sixteen hours later, 10 ml of fresh medium was applied. Stable transfectants were selected by treatment with geneticin (800 ng/ml; GIBCO-BRL) for 3 weeks, and colonies (> 100) were pooled. Transfectants were induced to differentiate with either 4 mM N,A^-hexamethylenebisacetamide (HMBA) or 1.6% dimethylsulfoxide (DMSO) for up to 7 days.
RESULTS

Identification of ris-control regions
To search for any tissue-specific cw-control regions within the 15-lox genomic DNA regions available, a 'mini-gene' was constructed containing a fragment of 5'-flanking DNA from -2.7 kb to +20 bp linked upstream of the CAT-gene and 4.6 kb of 3'-flanking 15-lox gene DNA from +8 to +12.6 kb linked 3' to the CAT gene. For comparison, constructs containing 5' flanking DNA from -40 to +20 bp (pCAT-40), -150 to +20 bp (pCAT-150) and -2.7 kb to +20 bp (pCAT-2700) linked upstream of the CAT gene were also used (Fig. 1A) . Each of these constructs was transfected into mouse erythroid (MEL) or epithelial (C5) cells and the CAT activity measured 48 h later and standardised against the activity of a co-transfected (3-galactosidase expression construct, pHSVpGal. The results (Fig. 1A) show that the pCAT-40 had virtually no promoter activity in either cell line, whereas pCAT-150 had similar levels of activity in both cell types [as compared with a 109 bp murine thymidine kinase gene promoter construct (data not shown)]. Both the mini-gene and pCAT-2700 had slightly higher activity (2-and 1.6-fold, respectively) than the pCAT-150 in MEL cells; whereas they had very little activity in C5 cells (Fig. 1 A) . This experiment shows that the genomic DNA sequences surrounding the 15-lox gene suppress the promoter activity in C5 cells but not MEL cells and that the regions responsible are located primarily in the 2.7 kb of 5' flanking DNA.
Similar results were obtained using constructs containing the human growth hormone gene as a reporter; however attempts to analyse CAT and growth hormone mRNA levels and transcription start sites by S1 mapping or RNAse protection in these experiments has proven to be impossible due to the instability of the mRN A, the low levels of promoter activity and the relatively inefficient transfection of the cells in our transient assays.
Defining the tissue-specific silencer
To determine whether the down-regulation of 15-lox promoter activity was a peculiarity of MEL cells, the pCAT-150 and pCAT-2700 constructs were introduced into another erythroid cell line of human origin (K562) and a variety of fibroblast or epithelial cell lines of mouse, human or rabbit origin (C5 epithelial cells, the STO mouse fibroblast line; R9AB and Rab9 rabbit skin and lung fibroblast-like lines). The results (Fig. IB) show that the pCAT-2700 construct was as active as the pCAT-150 construct in both erythroid cell lines, whereas it had very low activity in all the other cell lines.
To define the location of the sequences responsible for the down-regulation more precisely, a series of 5' deletions of the 15-lox DNA in pCAT-2700 were constructed and tested by transfection into MEL, C5 and Rab 9 cells as before. The results ( Fig. 2A) show that down regulation in non-erythroid cells is gradually lost as the 5' flanking DNA is progressively deleted from-930 to-315 bp.
To test whether the down-regulation was due to a transcriptional silencer, the 2.55 kb fragment from -2.7 kb to -150 bp was cloned in either the natural or opposite orientation 5' or 3' to the CAT gene in pCAT-150 and the effect of promoter activity determined after transfection into MEL or C5 cells. The results in C5 cells showed that CAT activity was reduced -20-fold with 2.55 kb fragment placed 5' in either orientation when compared with pCAT-150 alone (Fig. 2B , lines 5 and 6); when placed 3', the negative effect was lower (~2-fold) (Fig. 2B, lines 7 and 8 ), but still significant. However, the negative effect was not apparent in MEL cells (Fig. 2B, lines 5-8) . A reduction in CAT activity in C5 cells was also found with a 780 bp fragment from -150 to -930 bp inserted 5' in either orientation (Fig. 2B, lines 1 and 2) , although the effect (5-6-fold) was not as large as with the 2550 bp fragment; again the down-regulation was -2-fold when the 780 bp fragment was placed 3' (Fig. 2B, lines 3 and 4) . These results show that the 780 bp fragment of the 15-lox gene contains a transcriptional silencer.
To determine whether the silencer functions in a promoterspecific way, the 2.55 kb 5' 15-lox gene fragment was cloned in its 'natural' orientation upstream of a 289 bp minimal promoter from the glutathione peroxidase (GPX) gene linked to the CAT gene in plasmid pGPY289 (5) to give pGPY289/2.551ox. We have previously shown that the minimal 289 bp GPX promoter works equally well in both MEL and C5 cells (5) . Silencer function was then assessed by comparing the promoter activity of pGPY289/2.551ox with pGPY289 after transfection into eythroid cells (MEL) or non-erythroid cells (C5 or Rab9 cells); the results were then compared with those using the pCAT-2700 and pCAT-150 15-lox gene constructs transfected in parallel experiments. The results (Fig. 2C) show that the 15-lox silencer funtions much more strongly with its homologous promoter than with the GPX promoter.
Nuclear proteins binding to the silencer
To locate any binding sites for nuclear factors in the silencer region, the first 930 bp of 5'-flanking DNA was subjected to DNase I footprinting, using the eight end-labelled fragments shown in Figure 3A . All the footprints (FPs) detected are displayed against the 15-lox gene sequence in Figure 4A . Eleven reproducible FPs were detected in the region from the transcription start site to -930 bp (Fig. 3B-F, summarised in Fig. 4A ). Non-erythroid-specificfactors) binding to the silencer fragment. FPs 4-7 and 10 ( Fig. 3C-E) within the silencer fragment from -150 to -930 bp are only found with non-erythroid (C5) nuclear extracts. In fact, the sequences of the FP4,5,6 and 7 regions (Fig.  4A ) are remarkably similar (Fig. 4B) and oligonucleotides from the FP4 or FP5 regions compete the binding to FPs 7 and 10 strongly (Fig. 3D and F) , suggesting that FPs 4-7 and 10 all bind the same C5 cell factor. This is also confirmed by EMSA experiments showing that at least two specific retarded complexes are formed with an oligonucleotide from the FP4 region with three different non-erythroid cell extracts (C5, HeLa and Rab9) (Fig. 5A, bands 1 and 2) ; these FPs are competed by oligonucleotides from the FP4,5,7 and 10 regions (Fig. 5B) , but not by an oligonucleotide containing a mutated version of FP5 (FP5M; see Fig. 4 ), nor by oligonucleotides containing binding sites for the NF1 or Oct-1 factors (Fig. 5B) . Interestingly, another oligonucleotide [M, (Fig. 4A) ] from the 15-lox flanking region containing sequences similar to the FP4-6, 10 consensus also competes with FP5 in EMSAs (Fig. 5B) , although this region and another region, N (Fig. 4A) , showed only weak binding in footprinting experiments (data not shown). The faster migrating complexes in some tracks appear to be non-specific since they are not competed by a 200-fold excess of unlabelled FP4 oligonucleotide in Rab9 extracts (Fig. 5 A) . The nuclear factor binding to the 15-lox silencer elements is not the well characterised negative regulator known as YY1,5, NF-E1 or UCRBP (37-40), since an oligonucleotide containing the FP4 binding site does not compete for nuclear proteins binding to an oligonucleotide containing the YYl binding site (Fig. 5C ).
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The footprint 8 region. The footprinting experiment shown in Figure 3E shows that both erythroid and non-erythroid cells contain factors capable of binding to this region in vitro. Since inspection of the 15-lox gene sequence in the FP8 region revealed three potential binding sites for GATA-1 (Fig. 4A) , the nature of the factors binding to this region in erythroid and non-erythroid cells was investigated further by EMSA (Fig. 6) . These experiments clearly show the same series of multiple retarded complexes (Fig. 6, bands 2-5 ) with both MEL and C5 nuclear extracts, except for an extra complex (Fig. 6, band 1) found only with MEL nuclear extracts. Competition experiments show that the slowest migrating complex (Fig. 6, band 1) found only with MEL extracts is competed with a GATA-1 binding site from the mouse a-globin promoter, whereas the other retarded complexes are not (Fig. 6) . Conversely, an FP8 oligonucleotide mutated in each of the three GATA sites competes out bands 2-5 common to both MEL and C5 extracts, but not band 1 (Fig. 6) . The erythroid-specific complex is also preferentially competed by an oligonucleotide from the FP8 region mutated in the regions between the three GATA sites (data not shown). These data show that both erythroid and non-erythroid cells contain factor(s) binding to sequences in the FP8 region between the GATA sites, but this does not prevent the GATA-1 in erythroid cells binding to the GATA sites, at least in vitro. The factor(s) responsible for these non-tissue-specific retarded complexes are not the same as those binding to FPs 4-7 and 10 since a FP4 olignucleotide does not compete (Fig. 6) .
Other binding sites. Two other FPs were found. One, FP9, is only found with MEL extracts (Fig. 3E and F) , but the nature of the erythroid factor binding is unknown: the sequence of the binding site bears no obvious similarity to those of other erythroidspecific factors. The other, FP11, is found with both MEL and C5 extracts (Fig. 3E) and is almost certainly due to binding of NF1, since it is competed by an oligonucleotide containing an NFl-binding site (Fig. 3F ).
C.
Multiple copies of the FP4 or FP5 regions alone act as tissue-specific negative regulators
The nuclear protein binding experiments described above strongly suggest that the binding of a nuclear factor to the FP4-7 and 10 regions is involved in the function of the 15-lox silencer.
To test this directly, four tandem copies of the FP4 sequence, or two copies of the FP5 sequence, were cloned upstream of the 15-lox minimal promoter in pCAT-150 and their effects on promoter activity assayed after transfection into MEL or C5 cells. The results (Fig. 7) show an 80% reduction of promoter activity in C5 and Rab9 cells, whereas only a 10% reduction is evident in MEL cells. This indicates that tandem copies of the FP4 and FP5 sequences act in isolation as tissue-specific negative regulators of the minimal 15-lox promoter.
The role of the FP8 triplet GATA region?
The transient transfection experiments shown in Figure 2 show that the 930 bp promoter fragment containing the GATA sites gives only a small increase (20%) in erythroid cells compared with the minimal 150 bp promoter. To determine whether the GATA region might function late in erythroid differentiation, stable transfectants were generated containing the pCAT-150, pCAT-930, pCAT-2700 or mini-gene constructs and the promoter activity measured after induction of differentiation by treatment for 5 days with 4 mM HMBA or 1.6% DMSO. To control for the effects of position of integration site in individual transfectants, pools of at least 100 transfectant clones were analysed. However, promoter activity was not increased for any of the constructs during MEL cell differentiation (data not shown). Similarly, stable MEL transfectants containing the FP8 or FP8-11 regions linked directly to the minimal 150 bp lox promoter [pCAT-150(GS) and pCAT-150(GL)] did not show increased promoter activity on induction of differentiation. One hypothesis concerning the role of the triplet GATA region is that binding of the ubiquitous factors to this region repress the 15-lox gene but GATA-1 releases this repression. This seems not be correct since a CAT construct containing the FP8 region linked to the -150 bp lox promoter [pCAT-150(GS)] does not show down-regulated expression in non-erythroid C5 cells in which GATA-1 is not expressed (data not shown). Alternatively, activation of transcription by GATA-1 could be repressed by the binding of the non-tissue-specific factors at the adjacent sites: these factors might only disappear from erythroid cells at late stages of erythroid maturation. To examine whether the factors binding to the non-tissue-specific sites decrease during MEL differentiation relative to the GATA-1 level, EMSA experiments with the FP8 oligonucleotide were performed using extracts from MEL cells at different stages of erythroid maturation. However, even after 5 days of induction with 1.6% DMSO the relative levels of erythroid and ubiquitous factors remain constant (data not shown). We have therefore been unable to obtain evidence that the GATA and FP9 regions have a functional role in the regulation of the 15-lox gene.
DISCUSSION
The major conclusion from our functional studies is that the 15-lox gene contains multiple copies of negative elements distributed throughout at least 1 kb of 5' flanking DNA that only function in non-erythroid cells and collectively have the properties of a transcriptional silencer. These elements bind nuclear factor(s) [repressor(s)] present in cells in which the 15-lox gene is not expressed (various fibroblast and epidermal cell lines of mouse, rabbit and human origin). All the sites appear to bind the same factor, as judged by the fact that the retarded complexes formed with each of the sites in EMSA experiments migrate at the same position and are competed by oligonucleotides containing the other sites. In contrast, the 15-lox gene repressor is not present, or at least cannot bind, in cells from the erythroid lineage in which the 15-LOX is expressed (mouse and human erythroid cell lines). We have been unable to test whether these silencer elements are non-functional in other cell types in which the 15-LOX is expressed (airway epithelial cells and eosinophils) due to the lack of suitable cell lines. Also, it has not been possible to analyse endogenous 15-LOX gene expression in the cell lines used in this study since the rabbit probes do not cross-hybridize with mouse and human genomic DNA or mRNA even at low stringency (data not shown). Evidence has recently accumulated for the importance of negative control of transcription of genes in a wide variety of contexts (reviewed in 6-11). In general terms, the 15-lox silencer elements resemble the tissue-specific silencers involved in the lineage-specific regulation of the immunoglobulin K (41) and T cell receptor (42) genes which may involve Oct-2 (43) . Silencers have also recently been defined upstream of the human y and e globin genes (13, 15, 44) and the well characterised zinc-finger protein known as YY1, 5, NF-E1 or UCRBP (37) (38) (39) (40) has been implicated in their activity. YY1 is of considerable interest since it can act either as an activator (40, (45) (46) (47) or as a repressor (15, 37, 38, 40) of transcription, depending on the context and the other nuclear factors with which it interacts (reviewed in 6). However, YY1 appears not to be the factor binding to the 15-lox silencer, since this factor is tissue-specific, whereas YY1 is ubiquitous, and an oligonucleotide containing the 15-lox silencer repressor binding site does not compete for the binding of factors to the YY1 binding site in EMSA experiments. Thus, the identity of the factor binding to the multiple 15-lox silencer elements remains unknown.
Positive control of LOX expression?
Positive control of erythroid-specific expression, mediated at least in part by members of the GATA family of transcription factors, has been a major feature of the regulation of globin genes and a variety of other genes expressed in an erythroid-specific manner (1,2,3,5,18,23). The 5'-flanking region of the 75-/<xt gene contains a cluster of three binding sites for GATA proteins, presumably GATA-1, at about -750 bp. These are the only motifs conforming to the GATA-1 binding site consensus sequence (WGATAR) present in the 10 kb of 15-lox gene sequence presently available (31) . However, using approaches that we have found to be successful in identifying positive cw-control regions involved in the erythroid-specific expression of other genes (1,2,5), we have failed to detect such regions by functional experiments with the 15-lox genomic fragments available, which contain 2.7 and 4.6 kb of 5' and 3' flanking DNA, respectively. None of the reporter constructs containing any or all of these 15-lox gene regions, including the 'mini-gene' (Fig. 1A) , have much greater promoter activity than the minimal 150 bp 15-lox promoter when introduced into erythroid cells in transient transfection experiments (a maximum of 2-fold for the mini-gene construct); nor do the constructs function more efficiently when stable erythroid cell transfectants are induced to differentiate. Introns 4 and 7 contain multiple copies of sequences resembling core enhancer motifs (G/TTGGA/TA/TA/TG) and the GGTGG motif found in many erythroid genes [located at nucleotides 2531-2560 and 4006-4438 (31)]: however, these do not have enhancer function when tested by transfection experiments in either erythroid or non-erythroid cells (data not shown).
We suspect that the reason why the GATA sites do not appear to confer erythroid-specific transcription in these experiments is due to the fact that the region between the GATA sites also binds other, ubiquitous, nuclear proteins. One possibility is that these proteins repress the 15-lox gene in non-expression tissues and that the binding of GATA-1 releases this repression in erythroid cells. However the FP8 region does not function as a repressor in C5 cells when linked to the minimal 150 bp 15-lox gene promoter. An alternative hypothesis is that the ubiquitous factors prevent activation of the 15-lox gene by GATA-1 and that 15-lox gene transcription requires loss of these factors during erythroid cell maturation. However, our evidence shows that this is not the case. Therefore, the role of the FP8 region in 15-lox gene expression remains unclear.
The sequence to which the ubiquitous protein(s) bind adjacent to the GATA sites is very AT-rich and remarkably similar to an AT-rich region at about -550 bp in the human (J-globin gene promoter: this region is of functional importance since sequence variations affecting binding of a putative repressor protein to this region of the p-globin sickle allele (P s ) also affect expression of the P s allele in a similar way (12, 14) . In some respects, this region containing GATA and other nuclear protein binding sites has also very similar characteristics to a region at about -75 bp in the human glycophorin B promoter where GATA binding displaces binding of a repressor to an adjacent site and allows transcription (23) . However, the sequence of the glycophorin gene repressor binding site has no obvious similarity with the lox gene binding site and does not compete in EMSA experiments (data not shown). A similar mechanism of repressors binding to sites overlapping transcription factor binding sites has also been shown to occur with the chicken lysozyme gene (48) and the rat platelet 4 gene (49) .
Thus, to summarise, our data demonstrate the importance of repressor proteins involved in the activity of the 15-lox gene silencer which appear to be involved in preventing 15-lox gene expression in inappropriate cell types. The factor is not present, or is unable to bind to the multiple silencer elements in erythroid cells for some reason, perhaps because it is complexed with an erythroid-specific factor such as GATA-1 or SCLTTal. Other factors present in both erythroid and non-erythroid cells may be involved in preventing activation of transcription by GATA-1, possibly by binding at adjacent sites.
